Dimethyl fumarate as a versatile therapeutic agent: molecular mechanisms and potential clinical applications. [PDF]
Zingkou E +5 more
europepmc +1 more source
Cytomegalovirus Infection in a Multiple Sclerosis Patient on Dimethyl Fumarate. [PDF]
Larsen N.
europepmc +1 more source
Comparative Effectiveness of Diroximel Fumarate vs. Dimethyl Fumarate in Persons with Multiple Sclerosis: A US Claims Analysis of Relapse Outcomes. [PDF]
Bandari D +13 more
europepmc +1 more source
Repurposing dimethyl fumarate for cancer therapy: current evidence and future directions. [PDF]
Zhang M, Jing Y, Cui Q.
europepmc +1 more source
Vitamin D<sub>3</sub> and Dimethyl Fumarate Partially Restore Neurotrophic Signaling Without Altering Mitochondrial Integrity in the STZ-Induced Model of Sporadic AD. [PDF]
Piekarczyk N +4 more
europepmc +1 more source
Acute retinal necrosis associated with dimethyl fumarate. [PDF]
Paisey C, Curtin K, Epps SJ, Rice CM.
europepmc +1 more source
A Retrospective Study of 116 Multiple Sclerosis Patients with Dimethyl Fumarate Treatment in a Single Institution in Japan. [PDF]
Sato S +7 more
europepmc +1 more source
Dimethyl fumarate combined with cisplatin at subcytotoxic doses sensitizes cervical cancer toward ferroptosis and apoptosis through GSH restriction and p53 (re)activation. [PDF]
Punziano C +6 more
europepmc +1 more source
A Randomised, Double-Blind Study Comparing the Gastrointestinal Tolerability of Tegomil Fumarate Versus Dimethyl Fumarate in Healthy Volunteers. [PDF]
Fonseca M +4 more
europepmc +1 more source
Elective First-Line Use of Dimethyl Fumarate in Psoriasis: Insights from an Italian Cohort. [PDF]
Giunta A +17 more
europepmc +1 more source

